Monitoring propranolol treatment in periocular infantile haemangioma View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2014-11

AUTHORS

R Burne, R Taylor

ABSTRACT

OBJECTIVE: To develop a tool for assessing amblyopic risk and monitoring the treatment effect of propranolol in periocular haemangioma management. METHODS: We present a study of nine children with periocular haemangioma who underwent propranolol treatment at York Hospital between 2009 and 2013.A proposed measure of amblyogenic risk based on the induced anisometropia resulting from a periocular haemangioma was calculated in the form of a single quantitative value, measured in dioptres. This calculation used published work and developed it to produce a new function, termed the delta defocus equivalent (DFE-∂).Refraction measurements were retrospectively collected from patients' notes in order to measure the trend of DFE-∂ over the treatment period with propranolol. RESULTS: The average DFE-∂ at commencement of propranolol was 1.54 (±0.62) D. The average at the end of treatment was 0.39 (±0.38) D. CONCLUSION: This work presents a possible tool for assessing amblyopic risk in cases of periocular infantile haemangioma. The DFE-∂ gives a measure in dioptres, which may represent the true amblyopic risk, and so be useful in supporting treatment decisions in paediatric ophthalmology. More... »

PAGES

1281-1285

Identifiers

URI

http://scigraph.springernature.com/pub.10.1038/eye.2014.237

DOI

http://dx.doi.org/10.1038/eye.2014.237

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1043249771

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/25323853


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1117", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Public Health and Health Services", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Administration, Oral", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adolescent", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adrenergic beta-Antagonists", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Amblyopia", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Child", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Child, Preschool", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Drug Monitoring", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Eyelid Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Hemangioma", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Infant", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Orbital Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Propranolol", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Refraction, Ocular", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Retrospective Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Risk Assessment", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Visual Acuity", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Young Adult", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Hull York Medical School", 
          "id": "https://www.grid.ac/institutes/grid.413631.2", 
          "name": [
            "Hull York Medical School, Heslington, York, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Burne", 
        "givenName": "R", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "York Hospital", 
          "id": "https://www.grid.ac/institutes/grid.417375.3", 
          "name": [
            "Ophthalmology Department, York Hospital, York, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Taylor", 
        "givenName": "R", 
        "id": "sg:person.01366364604.16", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01366364604.16"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1136/bjophthalmol-2011-300047", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000004025"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmc0708819", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1019302191"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/eye.2011.233", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1025833378", 
          "https://doi.org/10.1038/eye.2011.233"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0886-3350(13)80312-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1026101418"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0002-9394(14)78109-7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1026485403"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1542/peds.2012-1691", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1027114703"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ajo.2012.06.021", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031951898"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ajo.2010.07.022", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1034890388"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/eye.2012.48", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1037626358", 
          "https://doi.org/10.1038/eye.2012.48"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1001/archophthalmol.2011.40", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1041058827"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1001/archopht.1991.01080010072036", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1049866591"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1542/pir.15-7-266", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1067832558"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2014-11", 
    "datePublishedReg": "2014-11-01", 
    "description": "OBJECTIVE: To develop a tool for assessing amblyopic risk and monitoring the treatment effect of propranolol in periocular haemangioma management.\nMETHODS: We present a study of nine children with periocular haemangioma who underwent propranolol treatment at York Hospital between 2009 and 2013.A proposed measure of amblyogenic risk based on the induced anisometropia resulting from a periocular haemangioma was calculated in the form of a single quantitative value, measured in dioptres. This calculation used published work and developed it to produce a new function, termed the delta defocus equivalent (DFE-\u2202).Refraction measurements were retrospectively collected from patients' notes in order to measure the trend of DFE-\u2202 over the treatment period with propranolol.\nRESULTS: The average DFE-\u2202 at commencement of propranolol was 1.54 (\u00b10.62)\u2009D. The average at the end of treatment was 0.39 (\u00b10.38)\u2009D.\nCONCLUSION: This work presents a possible tool for assessing amblyopic risk in cases of periocular infantile haemangioma. The DFE-\u2202 gives a measure in dioptres, which may represent the true amblyopic risk, and so be useful in supporting treatment decisions in paediatric ophthalmology.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1038/eye.2014.237", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1097007", 
        "issn": [
          "0950-222X", 
          "1476-5454"
        ], 
        "name": "Eye", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "11", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "28"
      }
    ], 
    "name": "Monitoring propranolol treatment in periocular infantile haemangioma", 
    "pagination": "1281-1285", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "ce0364452c7520a86406bdb1b554ce414f75723b74f3b9d7cb9fe123c0f8c447"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "25323853"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "8703986"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1038/eye.2014.237"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1043249771"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1038/eye.2014.237", 
      "https://app.dimensions.ai/details/publication/pub.1043249771"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-10T17:19", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8672_00000426.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://www.nature.com/articles/eye2014237"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/eye.2014.237'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/eye.2014.237'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/eye.2014.237'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/eye.2014.237'


 

This table displays all metadata directly associated to this object as RDF triples.

196 TRIPLES      21 PREDICATES      61 URIs      41 LITERALS      29 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1038/eye.2014.237 schema:about N009b9b64b1a54ac39cc42c6ad77beb74
2 N0eee15c2ce3c40b685d1db257cd4c96d
3 N17b84158e2534e7d914d4b0dece6dcaa
4 N3655a5e9afb1415898fda65560d278b9
5 N375040a7a84546ecb0a02218e9890b30
6 N3ab8a45155614fbea493957dcf236bf4
7 N4d3bbc68d9db49218d545e58c86cd442
8 N55cc58670ce54c2fb8c39db9c24dff24
9 N5e32ad664e6c4be18e4d51149ee06f06
10 N615a5a685dfd4a3785e50ac4128aa156
11 N7115c38b3ad3409b9ad9e6ad33945648
12 N84f2fee9633c49178d779fe995effe0c
13 N97cbb555aeb043229bb760c724f1121b
14 N9af233737f2f40ecb7efb32eb67b8ddf
15 Nc7e49623c1bb409a93b29b2471a0fd24
16 Ncb961b39222e459db36427a8cef0bf96
17 Nd6974b99e2dd475987d16e9bddb19c41
18 Nf288503b13bc407394879924399fcbe0
19 Nf28f38c37c2840bbb13f070ecfe08e19
20 Nf2b2c41ba99a4f2f8fa96d5904fc8a14
21 anzsrc-for:11
22 anzsrc-for:1117
23 schema:author N3fa6a115cc214c84b53c512b015f19c6
24 schema:citation sg:pub.10.1038/eye.2011.233
25 sg:pub.10.1038/eye.2012.48
26 https://doi.org/10.1001/archopht.1991.01080010072036
27 https://doi.org/10.1001/archophthalmol.2011.40
28 https://doi.org/10.1016/j.ajo.2010.07.022
29 https://doi.org/10.1016/j.ajo.2012.06.021
30 https://doi.org/10.1016/s0002-9394(14)78109-7
31 https://doi.org/10.1016/s0886-3350(13)80312-4
32 https://doi.org/10.1056/nejmc0708819
33 https://doi.org/10.1136/bjophthalmol-2011-300047
34 https://doi.org/10.1542/peds.2012-1691
35 https://doi.org/10.1542/pir.15-7-266
36 schema:datePublished 2014-11
37 schema:datePublishedReg 2014-11-01
38 schema:description OBJECTIVE: To develop a tool for assessing amblyopic risk and monitoring the treatment effect of propranolol in periocular haemangioma management. METHODS: We present a study of nine children with periocular haemangioma who underwent propranolol treatment at York Hospital between 2009 and 2013.A proposed measure of amblyogenic risk based on the induced anisometropia resulting from a periocular haemangioma was calculated in the form of a single quantitative value, measured in dioptres. This calculation used published work and developed it to produce a new function, termed the delta defocus equivalent (DFE-∂).Refraction measurements were retrospectively collected from patients' notes in order to measure the trend of DFE-∂ over the treatment period with propranolol. RESULTS: The average DFE-∂ at commencement of propranolol was 1.54 (±0.62) D. The average at the end of treatment was 0.39 (±0.38) D. CONCLUSION: This work presents a possible tool for assessing amblyopic risk in cases of periocular infantile haemangioma. The DFE-∂ gives a measure in dioptres, which may represent the true amblyopic risk, and so be useful in supporting treatment decisions in paediatric ophthalmology.
39 schema:genre research_article
40 schema:inLanguage en
41 schema:isAccessibleForFree true
42 schema:isPartOf N8660a63bc668474b97f755c340848690
43 Nc24ea9e824234f83ba6b2f0a6fab9739
44 sg:journal.1097007
45 schema:name Monitoring propranolol treatment in periocular infantile haemangioma
46 schema:pagination 1281-1285
47 schema:productId N086ea5245f4047059dedb5c3d48cec8b
48 N193e3c095a494dcb84d7dfe3074486fd
49 N2429456b713a4ec1a661956f3bad4459
50 N59b8d541bc4043feb3c6ed7331cd5b3a
51 Nc20b4aa043264601a4a664d5e90311f6
52 schema:sameAs https://app.dimensions.ai/details/publication/pub.1043249771
53 https://doi.org/10.1038/eye.2014.237
54 schema:sdDatePublished 2019-04-10T17:19
55 schema:sdLicense https://scigraph.springernature.com/explorer/license/
56 schema:sdPublisher Nf3b591c60cad475eb43afa00258b101e
57 schema:url https://www.nature.com/articles/eye2014237
58 sgo:license sg:explorer/license/
59 sgo:sdDataset articles
60 rdf:type schema:ScholarlyArticle
61 N009b9b64b1a54ac39cc42c6ad77beb74 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
62 schema:name Male
63 rdf:type schema:DefinedTerm
64 N086ea5245f4047059dedb5c3d48cec8b schema:name pubmed_id
65 schema:value 25323853
66 rdf:type schema:PropertyValue
67 N09591f92b0454c30b135a0815941565e rdf:first sg:person.01366364604.16
68 rdf:rest rdf:nil
69 N0eee15c2ce3c40b685d1db257cd4c96d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
70 schema:name Young Adult
71 rdf:type schema:DefinedTerm
72 N17b84158e2534e7d914d4b0dece6dcaa schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
73 schema:name Adolescent
74 rdf:type schema:DefinedTerm
75 N193e3c095a494dcb84d7dfe3074486fd schema:name dimensions_id
76 schema:value pub.1043249771
77 rdf:type schema:PropertyValue
78 N2429456b713a4ec1a661956f3bad4459 schema:name readcube_id
79 schema:value ce0364452c7520a86406bdb1b554ce414f75723b74f3b9d7cb9fe123c0f8c447
80 rdf:type schema:PropertyValue
81 N3655a5e9afb1415898fda65560d278b9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
82 schema:name Retrospective Studies
83 rdf:type schema:DefinedTerm
84 N375040a7a84546ecb0a02218e9890b30 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
85 schema:name Child
86 rdf:type schema:DefinedTerm
87 N3ab8a45155614fbea493957dcf236bf4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
88 schema:name Administration, Oral
89 rdf:type schema:DefinedTerm
90 N3fa6a115cc214c84b53c512b015f19c6 rdf:first N682a175bd5b8486fb3609b25b4b57962
91 rdf:rest N09591f92b0454c30b135a0815941565e
92 N4d3bbc68d9db49218d545e58c86cd442 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
93 schema:name Refraction, Ocular
94 rdf:type schema:DefinedTerm
95 N55cc58670ce54c2fb8c39db9c24dff24 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
96 schema:name Risk Assessment
97 rdf:type schema:DefinedTerm
98 N59b8d541bc4043feb3c6ed7331cd5b3a schema:name doi
99 schema:value 10.1038/eye.2014.237
100 rdf:type schema:PropertyValue
101 N5e32ad664e6c4be18e4d51149ee06f06 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
102 schema:name Drug Monitoring
103 rdf:type schema:DefinedTerm
104 N615a5a685dfd4a3785e50ac4128aa156 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
105 schema:name Humans
106 rdf:type schema:DefinedTerm
107 N682a175bd5b8486fb3609b25b4b57962 schema:affiliation https://www.grid.ac/institutes/grid.413631.2
108 schema:familyName Burne
109 schema:givenName R
110 rdf:type schema:Person
111 N7115c38b3ad3409b9ad9e6ad33945648 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
112 schema:name Infant
113 rdf:type schema:DefinedTerm
114 N84f2fee9633c49178d779fe995effe0c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
115 schema:name Orbital Neoplasms
116 rdf:type schema:DefinedTerm
117 N8660a63bc668474b97f755c340848690 schema:issueNumber 11
118 rdf:type schema:PublicationIssue
119 N97cbb555aeb043229bb760c724f1121b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
120 schema:name Adrenergic beta-Antagonists
121 rdf:type schema:DefinedTerm
122 N9af233737f2f40ecb7efb32eb67b8ddf schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
123 schema:name Visual Acuity
124 rdf:type schema:DefinedTerm
125 Nc20b4aa043264601a4a664d5e90311f6 schema:name nlm_unique_id
126 schema:value 8703986
127 rdf:type schema:PropertyValue
128 Nc24ea9e824234f83ba6b2f0a6fab9739 schema:volumeNumber 28
129 rdf:type schema:PublicationVolume
130 Nc7e49623c1bb409a93b29b2471a0fd24 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
131 schema:name Propranolol
132 rdf:type schema:DefinedTerm
133 Ncb961b39222e459db36427a8cef0bf96 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
134 schema:name Amblyopia
135 rdf:type schema:DefinedTerm
136 Nd6974b99e2dd475987d16e9bddb19c41 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
137 schema:name Child, Preschool
138 rdf:type schema:DefinedTerm
139 Nf288503b13bc407394879924399fcbe0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
140 schema:name Hemangioma
141 rdf:type schema:DefinedTerm
142 Nf28f38c37c2840bbb13f070ecfe08e19 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
143 schema:name Eyelid Neoplasms
144 rdf:type schema:DefinedTerm
145 Nf2b2c41ba99a4f2f8fa96d5904fc8a14 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
146 schema:name Female
147 rdf:type schema:DefinedTerm
148 Nf3b591c60cad475eb43afa00258b101e schema:name Springer Nature - SN SciGraph project
149 rdf:type schema:Organization
150 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
151 schema:name Medical and Health Sciences
152 rdf:type schema:DefinedTerm
153 anzsrc-for:1117 schema:inDefinedTermSet anzsrc-for:
154 schema:name Public Health and Health Services
155 rdf:type schema:DefinedTerm
156 sg:journal.1097007 schema:issn 0950-222X
157 1476-5454
158 schema:name Eye
159 rdf:type schema:Periodical
160 sg:person.01366364604.16 schema:affiliation https://www.grid.ac/institutes/grid.417375.3
161 schema:familyName Taylor
162 schema:givenName R
163 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01366364604.16
164 rdf:type schema:Person
165 sg:pub.10.1038/eye.2011.233 schema:sameAs https://app.dimensions.ai/details/publication/pub.1025833378
166 https://doi.org/10.1038/eye.2011.233
167 rdf:type schema:CreativeWork
168 sg:pub.10.1038/eye.2012.48 schema:sameAs https://app.dimensions.ai/details/publication/pub.1037626358
169 https://doi.org/10.1038/eye.2012.48
170 rdf:type schema:CreativeWork
171 https://doi.org/10.1001/archopht.1991.01080010072036 schema:sameAs https://app.dimensions.ai/details/publication/pub.1049866591
172 rdf:type schema:CreativeWork
173 https://doi.org/10.1001/archophthalmol.2011.40 schema:sameAs https://app.dimensions.ai/details/publication/pub.1041058827
174 rdf:type schema:CreativeWork
175 https://doi.org/10.1016/j.ajo.2010.07.022 schema:sameAs https://app.dimensions.ai/details/publication/pub.1034890388
176 rdf:type schema:CreativeWork
177 https://doi.org/10.1016/j.ajo.2012.06.021 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031951898
178 rdf:type schema:CreativeWork
179 https://doi.org/10.1016/s0002-9394(14)78109-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1026485403
180 rdf:type schema:CreativeWork
181 https://doi.org/10.1016/s0886-3350(13)80312-4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1026101418
182 rdf:type schema:CreativeWork
183 https://doi.org/10.1056/nejmc0708819 schema:sameAs https://app.dimensions.ai/details/publication/pub.1019302191
184 rdf:type schema:CreativeWork
185 https://doi.org/10.1136/bjophthalmol-2011-300047 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000004025
186 rdf:type schema:CreativeWork
187 https://doi.org/10.1542/peds.2012-1691 schema:sameAs https://app.dimensions.ai/details/publication/pub.1027114703
188 rdf:type schema:CreativeWork
189 https://doi.org/10.1542/pir.15-7-266 schema:sameAs https://app.dimensions.ai/details/publication/pub.1067832558
190 rdf:type schema:CreativeWork
191 https://www.grid.ac/institutes/grid.413631.2 schema:alternateName Hull York Medical School
192 schema:name Hull York Medical School, Heslington, York, UK
193 rdf:type schema:Organization
194 https://www.grid.ac/institutes/grid.417375.3 schema:alternateName York Hospital
195 schema:name Ophthalmology Department, York Hospital, York, UK
196 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...